Abstract
Pulmonary diseases (both acute and chronic) include asthma, acute lung injury, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary fibrosis and lung cancer. These diseases affect a significant percentage of the global population. Medicinal plants are gaining considerable attention as promising therapeutics in alleviating respiratory diseases. Advanced drug-delivery systems have become well established, particularly in the field of nanotechnology, which has taken on new significance as an emerging field in the management of inflammatory lung diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 1293-1295 |
| Number of pages | 3 |
| Journal | Future Medicinal Chemistry |
| Volume | 14 |
| Issue number | 18 |
| DOIs | |
| Publication status | Published - Sept 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- advances
- lung diseases
- nanoformulations
- nanoparticles
- rutin
Fingerprint
Dive into the research topics of 'Advances in research with rutin-loaded nanoformulations in mitigating lung diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver